DAYTON, Ohio–(BUSINESS WIRE)–MedsEngine, a provider of chronic disease management software, is proud to announce that it has successfully attained SOC 2 Type II certification. This certification, awarded by the American Institute of Certified Public Accountants (AICPA), is a rigorous audit that evaluates a company’s controls relevant to security, availability, processing integrity, confidentiality, and privacy.
Dr. Doug Romer, CMO, stated, “this milestone underscores MedsEngine’s continued commitment to safeguarding customer data and maintaining the highest standards of security. Our clients can trust that their data is protected by industry-leading security measures.”
For more information about MedsEngine and its SOC 2 Type II certification, visit www.medsengine.com.
About MedsEngine:
MedsEngine develops EHR-integrated clinical decision support applications that generate real-time, personalized, evidence-based medication recommendations for hypertension, cholesterol management, type 2 diabetes, and heart failure. Medical groups utilizing MedsEngine have seen nation-leading hypertension control, higher HEDIS scores and Star ratings, lower medical costs, standardized care across all providers, and greater patient understanding and satisfaction.
Contacts
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…
